Microcap Report: Immunovaccine (V.IMV), Eaglewood Energy (V.EWD), Largo (V.LGO) active

Immunovaccine Inc. (TSX:V.IMV, Stock Forum) jumped 18.6% to 83 cents Tuesday after the Halifax Nova Scotia-based biopharmaceutical firm said new positive clinical data on the company's lead cancer vaccine candidate, DPX-Survivac, will be presented as a poster to the 2014 ASCO Annual Meeting in Chicago, Illinois.

Immunovaccine is engaged in the discovery and development of immune system activators to treat cancer and prevent infectious diseases,

According to the news release, the vaccine's successful results stem from the Phase I/Ib clinical study which demonstrated promising early evidence in ovarian cancer patients including one patient who experienced a partial response (PR). The PR, defined as a shrinking of tumor size by at least 30% using Responsive Evaluation Criteria in Solid Tumors (RECIST 1.1), was accompanied by reduction in levels of a commonly used ovarian cancer biomarker (CA125) and a significant increase in vaccine-induced immune responses.

Eaglewood Energy Inc. (TSX: V.EWD, Stock Forum) rose 9% to 37 cents after the company released a “RETRANSMISSION” of a news release stating that it has struck a deal to be acquired by Transform Exploration Pty Ltd. for 38 cents a share.

Transform is an oil and gas company that is focused on the Australasian and South-East Asian regions, Eaglewood said in a press release.

Largo Resources Ltd. (TSX: V.LGO, Stock Forum) was up 7.5% to 28.5 cents. The Toronto company said it will host an inauguration ceremony at the Maracas Vanadium Project in Bahia, Brazil on Wednesday, May 21st, 2014.

Additionally, Largo said it has received its preliminary operating license for production at the Maracas project, the company said in a press release.